Carisma Therapeutics Overview

Carisma Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CARM.

Quarterly EBIT

$44.72M

↑ 452.05% YoY

As of Sep 30, 2025

Annual EBIT (TTM)

$20.95M

↑ 131.58% YoY

Trailing 12 months ending Sep 30, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin